Doris Zane

Doris Zane, PhD, DABT, is the Executive Director of Nonclinical Safety & Pathobiology at Gilead Sciences, a position held since 2020. Previously, Doris served as Executive Director of Nonclinical Development and Senior Director of Preclinical Development at Intarcia Therapeutics, Inc. Doris also held a role as Nonclinical Operations Senior Manager at Genentech and was Senior Director of Preclinical Research & Development at Trinity Biosystems. Doris's academic background includes a Bachelor of Arts in Molecular & Cellular Biology from the University of California, Berkeley, and both a Ph.D. in Molecular & Cellular Physiology from the University of California, Davis, and a Master of Science in Biological Science from Stanford University.